Search – Page 118 – Indianapolis Business Journal

Home » Search

Articles

Covance shareholder sues over $6.1B LabCorp deal

December 11, 2014

A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice. Covance has major laboratory operations in Indianapolis.

Lilly: $6.1M from businesses raised for preschool plan

December 11, 2014

The Indianapolis business community, led by Eli Lilly and Co., has already netted more than half of its goal to support the city’s recently approved preschool program to provide low-income families with early-education programs.

People in the news – Dec. 15, 2014

December 11, 2014

People in the news from the Dec. 15, issue of IBJ.

Alzheimer’s tests present dilemma of knowing the future

December 12, 2014

While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.

Lilly’s Cyramza gets new marketing approval

December 15, 2014

Eli Lilly and Co.'s drug Cyramza has been approved as a treatment for lung cancer, regulators said. The Food and Drug Administration is allowing Lilly to market the drug as a treatment for cases that have spread.

Company news

December 15, 2014

Infant mortality is improving in Indianapolis and around the state, but is still well above the national average, according to two reports last week. In Marion County, the infant mortality rate fell from a high of 12.9 per thousand births in 2009 to 8.3 per thousand in 2012, according to a Community Health Assessment released […]

Lilly bumps up dividend for first time since 2009

December 16, 2014

Shares of Eli Lilly and Co. were on the rise Tuesday morning, a day after the drugmaker announced its first dividend increase in more than five years.

People in the news – Dec. 22, 2014

December 18, 2014

Starting Jan. 2, 2015, People will be a paid feature in IBJ. Visit IBJ.com/submit-people for a rundown of options and prices.

Lilly reaches insulin development deal with Adocia

December 19, 2014

Eli Lilly and Co. could pay more than $570 million to French pharmaceutical company Adocia under an agreement to develop a fast-acting insulin that is in the early stages of clinical testing.

Company news

December 22, 2014

Round 2 of the fight over a nursing home construction ban will commence in January when the Indiana General Assembly convenes for its new session. Sen. Pat Miller, R-Indianapolis, told IBJ she will introduce a bill that would institute a three-year “moratorium” on construction of skilled nursing facilities. The moratorium is widely favored by nursing […]

Lilly to sell heartworm line for Novartis deal approval

December 24, 2014

Eli Lilly and Co. wants to combine Novartis with its own animal health business, Elanco, to create the second-largest animal health company in the U.S.

Company news

December 24, 2014

When patients get to edit their medical records, they tend to leave out important stuff. That was the conclusion of researchers at the Regenstrief Institute, the Indiana University School of Medicine and Eskenazi Health, after they conducted the first experiment ever in which real patients were allowed to control what parts of their medical records […]

Records – Jan. 5, 2015

December 31, 2014

Records listings from the Jan. 5, 2015, issue of IBJ.

UPDATE: Lilly forecasts earnings below analyst expectations

January 7, 2015

The Indianapolis-based drugmaker said its long-term strategy is on track, but predicted sales this year would be $20.3 billion to $20.8 billion, a shade below what Wall Street was expecting.

Local developer plans to raze homes for Broad Ripple apartment project

January 8, 2015

The $5 million, 24-unit project would be built on Winthrop Avenue just west of the Monon Trail, where five rental homes would need to be demolished.

Obamacare’s effects on Lilly: Modest pain, no gain

January 12, 2015

Since Obamcare was expected to boost insurance coverage nationally by 32 million people, drugmakers like Eli Lilly and Co. stood to benefit. But it’s not working out that way. At least not for Lilly.

UPDATE: Lilly says it couldn’t have made tainted Cialis

January 12, 2015

A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.

« Previous 1 … 116 117 118 119 120 … 221 Next »

Search Results

4,413 results for '\"eli lilly\"'

Articles

Covance shareholder sues over $6.1B LabCorp deal

Lilly: $6.1M from businesses raised for preschool plan

People in the news – Dec. 15, 2014

Alzheimer’s tests present dilemma of knowing the future

Lilly’s Cyramza gets new marketing approval

Company news

Lilly bumps up dividend for first time since 2009

People in the news – Dec. 22, 2014

Lilly reaches insulin development deal with Adocia

Company news

Lilly to sell heartworm line for Novartis deal approval

Company news

Records – Jan. 5, 2015

UPDATE: Lilly forecasts earnings below analyst expectations

Local developer plans to raze homes for Broad Ripple apartment project

Obamacare’s effects on Lilly: Modest pain, no gain

UPDATE: Lilly says it couldn’t have made tainted Cialis

Lilly sees insurers pushing harder for discounts

MAURER: Delph, Endocyte and the best of 2014

FDA mistakenly blamed Lilly for making Cialis-Viagra combo